Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.6912
+0.0468 (7.26%)
Oct 27, 2026, 4:00 PM EDT - Market closed
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $97.4 million as of October 27, 2026. It is the 25,301st most valuable company in the world and the 4,105th biggest in the United States. Its market cap has decreased by 47.08% in one year.
Market Cap
97.40M
Enterprise Value
68.62M
1-Year Change
-47.08%
Global Rank
Country Rank
#4,105 United States
Category
ChartMarket Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $97.40M, a decrease of -73.20%. That is a compound annual growth rate of -16.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 97.40M | -52.53% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 100.56M |
| Black Diamond Therapeutics | 100.54M |
| LENZ Therapeutics | 98.97M |
| Tevogen | 98.83M |
| Tenax Therapeutics | 98.52M |
| Coya Therapeutics | 96.65M |
| PMV Pharmaceuticals | 94.39M |
| PDS Biotechnology | 94.22M |